3-(4-chlorophenyl)-N-(6-methylbenzo[d]thiazol-2-yl)-1-phenyl-1H-pyrazole-4-carboxamide

ID: ALA4476739

PubChem CID: 155538686

Max Phase: Preclinical

Molecular Formula: C24H17ClN4OS

Molecular Weight: 444.95

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc2nc(NC(=O)c3cn(-c4ccccc4)nc3-c3ccc(Cl)cc3)sc2c1

Standard InChI:  InChI=1S/C24H17ClN4OS/c1-15-7-12-20-21(13-15)31-24(26-20)27-23(30)19-14-29(18-5-3-2-4-6-18)28-22(19)16-8-10-17(25)11-9-16/h2-14H,1H3,(H,26,27,30)

Standard InChI Key:  HAXZZJQOXVLTTC-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
    6.2321   -7.8871    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.8992   -7.4051    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6448   -6.6201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8235   -6.6201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5650   -7.4051    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2314   -8.7072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5179   -9.1152    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5176   -9.9357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2300  -10.3493    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9442   -9.9322    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9410   -9.1130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1095   -6.2115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3547   -6.2074    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0647   -6.6120    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3501   -5.3860    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.7742   -6.1994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5211   -6.5297    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.8495   -5.3843    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6519   -5.2057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0666   -5.9133    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8834   -5.9085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2865   -5.1969    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.8710   -4.4886    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.0555   -4.4968    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1112   -5.3872    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3980   -4.9745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6841   -5.3892    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.6878   -6.2166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.4015   -6.6215    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9712   -4.9783    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   12.1078   -5.1906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  4  5  2  0
  2  3  2  0
  1  2  1  0
  3  4  1  0
  5  1  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  1  6  1  0
  4 12  1  0
  3 13  1  0
 13 14  1  0
 13 15  2  0
 14 16  1  0
 16 17  1  0
 17 20  1  0
 19 18  1  0
 18 16  2  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 12 25  2  0
 25 26  1  0
 26 27  2  0
 27 28  1  0
 28 29  2  0
 29 12  1  0
 27 30  1  0
 22 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4476739

    ---

Associated Targets(Human)

HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
U-87 MG (3946 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HEK-293T (167025 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 444.95Molecular Weight (Monoisotopic): 444.0812AlogP: 6.36#Rotatable Bonds: 4
Polar Surface Area: 59.81Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.32CX Basic pKa: 0.70CX LogP: 7.13CX LogD: 7.13
Aromatic Rings: 5Heavy Atoms: 31QED Weighted: 0.35Np Likeness Score: -2.53

References

1. Reddy VG, Reddy TS, Jadala C, Reddy MS, Sultana F, Akunuri R, Bhargava SK, Wlodkowic D, Srihari P, Kamal A..  (2019)  Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model.,  182  [PMID:31445229] [10.1016/j.ejmech.2019.111609]

Source